Dorsomorphin (Compound C): Advanced Insights into AMPK and BMP Pathway Modulation

Introduction

The discovery and characterization of Dorsomorphin (Compound C) (SKU: B3252) have significantly advanced our understanding of the AMP-activated protein kinase (AMPK) and bone morphogenetic protein (BMP) signaling networks. As an ATP-competitive AMPK inhibitor and BMP signaling inhibitor, Dorsomorphin offers unparalleled precision for dissecting metabolic, autophagic, and developmental pathways in both basic and translational research. While previous literature has explored the dual actions and translational perspectives of Dorsomorphin, this article delivers a granular, mechanistic analysis with a focus on recent discoveries in autophagy regulation, iron metabolism modulation, and neural stem cell differentiation—addressing critical gaps in the current content ecosystem.

Mechanism of Action of Dorsomorphin (Compound C)

AMPK Inhibition: Molecular Details and Cellular Outcomes

Dorsomorphin functions as a cell-permeable and reversible ATP-competitive AMPK inhibitor, with a Ki value of 109 nM, demonstrating exceptional selectivity for AMPK over structurally related kinases such as PKA, PKC, and JAK3. By occupying the ATP-binding pocket of AMPK, Dorsomorphin blocks its kinase activity, resulting in the suppression of downstream phosphorylation events. Notably, it inhibits acetyl-CoA carboxylase (ACC) phosphorylation by up to 80%, a critical node in fatty acid metabolism and energy sensing. This blockade not only impairs the AMPK signaling pathway but also disrupts cellular energy homeostasis and autophagic flux, as evidenced by reduced autophagic proteolysis in various cellular models.

BMP/Smad Signaling Pathway Inhibition

Beyond its action on AMPK, Dorsomorphin potently inhibits the BMP/Smad signaling pathway by blocking Smad 1/5/8 phosphorylation. This antagonism suppresses BMP4-induced SMAD phosphorylation with an IC50 of 0.47 μM, impinging upon processes such as heterotopic ossification, hepatic hepcidin transcription, and neural fate determination. By reducing hepcidin levels, Dorsomorphin enhances serum iron concentrations—a feature with significant implications for systemic iron metabolism modulation.

Distinct Applications in Cellular and Animal Models

Inhibition of AMPK Activity in Hepatocytes and Cancer Research

Dorsomorphin’s utility in inhibition of AMPK activity in hepatocytes has enabled researchers to delineate the role of AMPK signaling in hepatic lipid metabolism, gluconeogenesis, and the pathogenesis of metabolic syndrome. In cancer research, Dorsomorphin serves as a crucial tool to interrogate the dependency of tumor cells on AMPK-mediated bioenergetic adaptation and autophagy regulation. Its ability to reversibly modulate AMPK activity facilitates both acute and chronic experimental paradigms, providing nuanced insights into tumor cell survival under metabolic stress.

Autophagy Regulation and Mitochondrial Quality Control

Recent advances have highlighted Dorsomorphin’s impact on autophagy and mitophagy. A pivotal study (Ren et al., 2025) demonstrated that pharmacological inhibition of AMPK with Dorsomorphin abrogates the beneficial effects of Lycium barbarum polysaccharide on AMPK/PINK1/Parkin-mediated mitophagy in skeletal muscle. Specifically, when AMPK was inhibited, the restoration of mitochondrial structure, membrane potential, and ATP levels in high-fat-diet-induced sarcopenic obesity models was completely reversed. This finding underscores AMPK’s central role in orchestrating selective autophagy and mitochondrial homeostasis, and positions Dorsomorphin as an indispensable negative control in autophagy research.

BMP4-Induced SMAD Phosphorylation Inhibition in Neural Stem Cell Differentiation

Dorsomorphin has emerged as a powerful BMP signaling inhibitor in neural stem cell research. By blocking BMP4-induced SMAD phosphorylation, it promotes neural induction and self-renewal in human embryonic stem cells. This selective BMP inhibition enables researchers to drive lineage specification and model early neurodevelopmental processes with high fidelity, offering translational value for regenerative medicine and disease modeling.

Comparative Analysis: Dorsomorphin Versus Alternative Approaches

While Dorsomorphin is a prototype ATP-competitive AMPK inhibitor, alternative compounds and genetic methods (such as CRISPR/Cas9-based knockouts or RNA interference) are also used to modulate AMPK and BMP pathways. However, Dorsomorphin’s rapid, reversible, and selective inhibition profile—combined with its dual action on AMPK and BMP/Smad signaling—offers unique experimental flexibility. Water and ethanol insolubility are mitigated by robust DMSO solubility (≥8.49 mg/mL with gentle warming), allowing precise dosing in cell culture (4–40 μM) and animal models (10 mg/kg i.p.).

In comparison to genetic approaches, chemical inhibition with Dorsomorphin offers temporal control and reversibility, essential for dissecting acute versus chronic effects in dynamic cellular systems. Its selectivity, however, must be considered in the context of potential off-targets and the need for appropriate negative controls, as emphasized in metabolic and autophagy studies.

Advanced Applications: Beyond the Basics

Iron Metabolism Modulation and Hepcidin Regulation

Dorsomorphin’s capacity to decrease hepatic hepcidin transcription and elevate serum iron levels has opened new avenues in the study of systemic iron homeostasis, anemia of inflammation, and related disorders. Animal studies demonstrate its efficacy in reducing hepatic hepcidin mRNA, which is tightly regulated by the BMP/Smad axis. These properties make Dorsomorphin a valuable probe for uncovering the interplay between BMP signaling, iron metabolism, and inflammatory responses.

Neural Stem Cell Differentiation and Regenerative Medicine

By antagonizing BMP/Smad signaling, Dorsomorphin facilitates the expansion and neural induction of embryonic stem cells. This application is particularly relevant for modeling neural differentiation pathways, elucidating neurodevelopmental disorders, and advancing protocols for neural tissue engineering. The precise control of BMP pathway inhibition enables the generation of neural precursors from pluripotent stem cells, accelerating the development of cell-based therapies.

Novel Insight: AMPK Inhibition in Muscle Atrophy and Mitophagy

A distinctive contribution of this article is the exploration of Dorsomorphin’s role in muscle atrophy and mitochondrial quality control, as elucidated in the aforementioned Ren et al. (2025) study. Here, Dorsomorphin was instrumental in demonstrating that the AMPK/PINK1/Parkin axis is essential for mitophagy-mediated muscle preservation under metabolic stress. Unlike prior reviews, we delve into the experimental use of Dorsomorphin as a negative regulator in this pathway, offering mechanistic clarity for researchers targeting sarcopenic obesity and related metabolic diseases. This perspective goes beyond the translational focus of previous articles, providing foundational insights for mitochondrial biology and therapeutic target validation.

Content Landscape: Building Upon and Differentiating From Existing Work

Previous thought-leadership articles, such as "Decoding AMPK and BMP Pathways: Strategic Insights for Translational Research", have provided a broad overview of the translational implications of Dorsomorphin’s dual inhibitory actions, with emphasis on emerging disease-modifying interventions and competitive perspectives. Our current article advances this discourse by focusing on mechanistic depth—particularly the role of Dorsomorphin in autophagy regulation, mitophagy, and mitochondrial integrity—areas only briefly referenced in prior work. By integrating the latest experimental evidence and highlighting Dorsomorphin’s utility as a negative control in mitophagy studies, we offer a differentiated, foundational resource for both basic and translational scientists.

Best Practices for Experimental Use

• Solubility and Storage: Dorsomorphin is insoluble in water and ethanol but can be dissolved in DMSO at concentrations ≥8.49 mg/mL with gentle warming and ultrasonic treatment. Store as a solid at -20°C. Solutions are not recommended for long-term storage.
• Recommended Concentrations: Use 4–40 μM in cell culture and 10 mg/kg (i.p.) in animal models, adjusting based on specific experimental needs and controls.
• Key Applications: Inhibition of AMPK activity in hepatocytes, BMP4-induced SMAD phosphorylation inhibition, neural stem cell differentiation, autophagy and mitophagy studies, and modulation of iron metabolism.

Conclusion and Future Outlook

Dorsomorphin (Compound C) stands at the nexus of metabolic, developmental, and regenerative biology. Its unique profile as an ATP-competitive AMPK inhibitor and BMP signaling inhibitor grants researchers unprecedented control over critical cellular pathways, enabling advanced investigations into autophagy regulation, iron metabolism, and neural differentiation. By incorporating recent mechanistic findings—such as its pivotal role in AMPK/PINK1/Parkin-mediated mitophagy—this article provides a robust foundation for future research and translational innovation.

For a comprehensive view on the strategic deployment and translational applications of Dorsomorphin, readers may refer to the previously published thought-leadership article. While that work charts the broader research landscape, our current analysis delivers mechanistic granularity and advanced application scenarios, supporting researchers seeking to design high-impact studies in metabolic disease, cancer, and regenerative medicine.